Penumbra PEN - オプションチェーン | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Penumbra Inc (PEN)
Penumbra Inc (PEN) オプション

Penumbra Inc (PEN)

262.34

5.10

(1.98%)

終値： 3月12日 5:00AM

262.34

0.00

( 0.00% )

取引時間後: 6:33AM

PEN ライブオプションフロー

オプションコール

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
180.00	80.70	84.50	0.00	82.60	0.00	0.00 %	0	0	-
185.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	66.30	69.60	0.00	67.95	0.00	0.00 %	0	0	-
200.00	61.30	64.70	0.00	63.00	0.00	0.00 %	0	0	-
210.00	51.40	54.80	0.00	53.10	0.00	0.00 %	0	0	-
220.00	41.70	45.10	0.00	43.40	0.00	0.00 %	0	0	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	23.10	26.20	0.00	24.65	0.00	0.00 %	0	0	-
250.00	15.00	17.30	25.08	16.15	0.00	0.00 %	0	1	-
260.00	8.20	10.90	44.20	9.55	0.00	0.00 %	0	2	-
270.00	3.60	6.50	20.40	5.05	0.00	0.00 %	0	7	-
280.00	1.05	3.00	7.70	2.025	0.00	0.00 %	0	165	-
290.00	0.30	3.30	3.03	1.80	0.00	0.00 %	0	2,523	-
300.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
310.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
320.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
330.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
340.00	1.85	1.55	1.85	1.70	0.00	0.00 %	0	400	-
350.00	0.00	1.55	0.00	0.00	0.00	0.00 %	0	0	-

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

オプションプット

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
180.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
185.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
190.00	0.00	1.35	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
200.00	1.12	1.60	1.12	1.36	0.00	0.00 %	0	2	-
210.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
220.00	0.05	1.80	0.42	0.925	0.00	0.00 %	0	7	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
250.00	2.85	4.80	1.95	3.825	0.00	0.00 %	0	15	-
260.00	5.70	8.10	8.90	6.90	1.50	20.27 %	2	250	2025/3/12
270.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
280.00	18.00	21.20	10.70	19.60	0.00	0.00 %	0	19	-
290.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
300.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
310.00	45.90	49.20	0.00	47.55	0.00	0.00 %	0	0	-
320.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
330.00	65.80	69.60	0.00	67.70	0.00	0.00 %	0	0	-
340.00	75.80	79.60	0.00	77.70	0.00	0.00 %	0	0	-
350.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
RAYRaytech Holding Ltd	US$ 1.69 (94.25%)	103.92M
TSVT2seventy bio Inc	US$ 4.945 (76.61%)	30.77M
HSAIHesai Group	US$ 24.10 (50.53%)	26.07M
SPHLSpringview Holdings Ltd	US$ 6.00 (47.06%)	1.62M
SYRSSyros Pharmaceuticals Inc	US$ 0.1334 (45.63%)	688.56M
WCTWellchange Holdings Company Limited	US$ 0.68417 (-72.74%)	37.49M
ARVNArvinas Inc	US$ 8.29 (-52.79%)	18.84M
LZMHLZ Technology Holdings Ltd	US$ 8.011 (-48.84%)	677.96k
HTCOHigh Trend International Group	US$ 1.41 (-33.80%)	164.95k
SPGCSacks Parente Golf Inc	US$ 0.1061 (-33.73%)	34.2M
SYRSSyros Pharmaceuticals Inc	US$ 0.1334 (45.63%)	695.41M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0402 (20.00%)	411.1M
NVDANVIDIA Corporation	US$ 108.76 (1.66%)	354.23M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 7.93 (7.45%)	304.26M
CUTRCutera Inc	US$ 0.1079 (-16.03%)	218.31M

@LaughinPaulRyan

@LaughinPaulRyan 4年前

... ALL NEWS IS GOOD? ... $PEN

CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

@LaughinPaulRyan

@LaughinPaulRyan 4年前

QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company

@LaughinPaulRyan

@LaughinPaulRyan 4年前

Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

davidsson10

davidsson10 4年前

https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

@LaughinPaulRyan

@LaughinPaulRyan 4年前

... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020

TREND1

TREND1 10年前

IPO INFO

http://www.marketwatch.com/tools/ipo-calendar

TREND1

TREND1 10年前

IPO NOW HAS SYMBOL
Penumbra PEN

TREND1

TREND1 10年前

IPO should be out soon.
no symbol yet.

Community Health Systems

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約